This new technique enables LLMs to dynamically adjust the amount of computation they use for reasoning, based on the difficulty of the question.

FDA Minutes Confirm Challenging Path Ahead for UniQure’s Huntington’s Gene Therapy  BioSpace

Today’s 9to5Toys Lunch Break is now ready to roll starting on a standout offer on the LTE 44mm Galaxy Watch 8 with one of the best deals to date at $160 off the list price (alongside offers on other models). We also still have the particularly notable offer on Galaxy Tab S11/Ultra with a FREE $210 keyboard case joined by a straight $400 cash discount on all Galaxy Tab S10 Ultra configs. But perhaps the most standout deal of all today is this insane $1,100 price drop on Samsung’s 2025 27-inch 3D 4K Odyssey gaming monitor. All of the details and even more offers await below.  more…

Kelun-Biotech and Crescent Biopharma form oncology partnership  Investing.com

FDA approved Novartis’ Itvisma, intrathecal onasemnogene abeparvovec, for SMA patients two years and older, including adults. Canada’s CORD midpoint shows Phase 1 funding for at least 12 drugs across nine conditions, urging broader screening and real world data. EMD Serono’s cladribine capsules earned FDA Fast Track in generalized myasthenia gravis, with Phase 3 underway. An EU op ed backs AI aligned with the European Health Data Space. Gene therapy momentum continues with Solid Biosciences, Latus Bio, Kedrion, and Regeneron–Tessera partnership.

The InnAIO T10 clips magnetically to the back of your phone, but it needs further development to be worth the money.

Get instant access to a concise analysis of 22 BioPharma (+ Google) CVCs and their portfolios. In minutes, you’ll see where strategic capital is flowing across Technology and Therapy Areas—and how 2025 trends compare to 2023. What’s inside: Clear mapping of CVC focus by Technology and Therapy Areas Trend shifts vs. 2023 to validate your thesis Actionable insights to spot momentum early How it works: Fill out the form to receive your report immediately. Questions or feedback? [email protected] LucidQuest empowers BioPharma executives and Life Sciences investors with up-to-date analysis. Stay tuned for 2025 deep dives on Cell & Gene Therapy, Digital Health, Oncology & Hematology, and more.

Plus, news about Pliant Therapeutics, Replicate Bioscience, Denali, Laigo Bio and Auxilius Pharma: ? UniQure's shares fall as it reiterates FDA's negative feedback on Huntington's study: The FDA

uniQure (QURE) Shares Plunge 20% on FDA Feedback for AMT-130  GuruFocus

LONDON–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of African Reinsurance Corporation (ARC) (Nigeria). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect ARC’s balance sheet strength, which AM Best assesses as strongest, as well as its strong operating …

Most organizations feel the imperative to keep pace with continuing advances in AI capabilities, as highlighted in a recent MIT Technology Review Insights report. That clearly has security implications, particularly as organizations navigate a surge in the volume, velocity, and variety of security data. This explosion of data, coupled with fragmented toolchains, is making it…

Crescent Biopharma made a set of sweeping moves Thursday morning, notably with its strategy of bringing its PD-1xVEGF to China. Boston-based Crescent signed a two-way deal with Kelun-Biotech, in which both companies will have access ...

uniQure (QURE) Reassesses Strategy After FDA Feedback on AMT-130 Application  GuruFocus

DUBLIN–(BUSINESS WIRE)–The “Competitor Analysis of Artificial Intelligence Market Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts” report has been added to ResearchAndMarkets.com’s offering. The international market for artificial intelligence was estimated at around US$ 184.15 billion in 2024. It is expected to expand at a compound annual growth rate (CAGR) …

A pioneering gene therapy from Nationwide Children's Hospital is bringing rare optimism to a field that has long struggled to develop such treatments for certain neurodevelopment disorders. In September, 8-year-old Maxwell Freed became the first ...

A pioneering gene therapy from Nationwide Children's Hospital is bringing rare optimism to a field that has long struggled to develop such treatments for certain neurodevelopment disorders. In September, 8-year-old Maxwell Freed became the first ...

Zanskar uses AI to identify hidden geothermal systems—and claims it has found one that could fuel a power plant, the first such discovery by industry in decades.

Zanskar uses AI to identify hidden geothermal systems—and claims it has found one that could fuel a power plant, the first such discovery by industry in decades.

uniQure Faces Setback in Gene Therapy Approval  TipRanks

Debut of the world’s first metaverse browser in June now opens development to everyone COLUMBUS, Ohio–(BUSINESS WIRE)–$AAPL #3dbrowser–Six months after unveiling the world’s first metaverse browser at AWE 2025, RP1 is officially opening access on December 8, 2025 for developers everywhere to plug into the open spatial internet. RP1 will release the first public suite …

Goldman Sachs upgrades Taysha Gene Therapies stock rating to Buy By Investing.com  Investing.com UK

Louisiana’s hunting and wildlife authority is one of more than 1,000 state and local agencies that have partnered with US immigration authorities this year alone.

Garmin has launched its own take on an end-of-year fitness summary, but you’ll need to pay to see it. The The post Garmin locks your yearly recap behind a paywall appeared first on Gadgets & Wearables.

This biweekly Rare Disease Video Recap highlights regulatory designations, early clinical progress, policy momentum, and strategic partnerships that are shaping […] The post Rare Disease Video Recap—December 4, 2025 appeared first on LucidQuest Ventures.

This Cardiovascular Video Recap covers mechanistic trial wins, national risk-mapping initiatives, new cardiovascular risk links, practical AI gains in procedural planning […] The post Cardiovascular Video Recap—December 4, 2025 appeared first on LucidQuest Ventures.